Europe Neuromodulation Devices Market Report 2016

December 2016 | 109 pages | ID: E3070FC7940EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Neuromodulation Devices

Revenue, means the sales value of Neuromodulation Devices

This report studies sales (consumption) of Neuromodulation Devices in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

• Medtronic, Inc.
• Boston Scientific Corporation
• St. Jude Medical, Inc
• Synapse Biomedical, Inc.
• Nevro Corporation
• Neurosigma, Inc.
• Neuropace, Inc.
• Neuronetics, Inc.
• Cyberonics, Inc.
• BioControl Medical

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Neuromodulation Devices in these countries, from 2011 to 2021 (forecast), like

• Germany
• France
• UK
• Russia
• Italy
• Spain
• Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Deep Brain Stimulation (DBS) Systems
• Spinal Cord Stimulator (SCS) Systems
• Diaphragm Pacing System (DPS)
• Respiratory Electrical Stimulation (RES)
• Vagus Nerve Stimulation (VNS)
• Gastric Electrical Stimulation (GES)
• Transcranial Magnetic Stimulation (TMS)
• Transcutaneous Electrical Nerve Stimulation (TENS)

Split by application, this report focuses on sales, market share and growth rate of Neuromodulation Devices in each application, can be divided into

• Chronic Pain
• Parkinson's disease
• Urine Incontinence
• Epilepsy
• Others

Contents

Europe Neuromodulation Devices Market Report 2016

1 NEUROMODULATION DEVICES OVERVIEW

1.1 Product Overview and Scope of Neuromodulation Devices
1.2 Classification of Neuromodulation Devices
  1.2.1 Deep Brain Stimulation (DBS) Systems
  1.2.2 Spinal Cord Stimulator (SCS) Systems
  1.2.3 Diaphragm Pacing System (DPS)
  1.2.4 Respiratory Electrical Stimulation (RES)
  1.2.5 Vagus Nerve Stimulation (VNS)
  1.2.6 Gastric Electrical Stimulation (GES)
  1.2.7 Transcranial Magnetic Stimulation (TMS)
  1.2.8 Transcutaneous Electrical Nerve Stimulation (TENS)
1.3 Application of Neuromodulation Devices
  1.3.1 Chronic Pain
  1.3.2 Parkinson's disease
  1.3.3 Urine Incontinence
  1.3.4 Epilepsy
  1.3.5 Others
1.4 Neuromodulation Devices Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Neuromodulation Devices (2011-2021)
  1.5.1 Europe Neuromodulation Devices Sales and Growth Rate (2011-2021)
  1.5.2 Europe Neuromodulation Devices Revenue and Growth Rate (2011-2021)

2 EUROPE NEUROMODULATION DEVICES BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Neuromodulation Devices Market Competition by Manufacturers
  2.1.1 Europe Neuromodulation Devices Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Neuromodulation Devices Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Neuromodulation Devices (Volume and Value) by Type
  2.2.1 Europe Neuromodulation Devices Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Neuromodulation Devices Revenue and Market Share by Type (2011-2016)
2.3 Europe Neuromodulation Devices (Volume and Value) by Countries
  2.3.1 Europe Neuromodulation Devices Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Neuromodulation Devices Revenue and Market Share by Countries (2011-2016)
2.4 Europe Neuromodulation Devices (Volume) by Application

3 GERMANY NEUROMODULATION DEVICES (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Neuromodulation Devices Sales and Value (2011-2016)
  3.1.1 Germany Neuromodulation Devices Sales and Growth Rate (2011-2016)
  3.1.2 Germany Neuromodulation Devices Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Neuromodulation Devices Sales Price Trend (2011-2016)
3.2 Germany Neuromodulation Devices Sales and Market Share by Manufacturers
3.3 Germany Neuromodulation Devices Sales and Market Share by Type
3.4 Germany Neuromodulation Devices Sales and Market Share by Application

4 FRANCE NEUROMODULATION DEVICES (VOLUME, VALUE AND SALES PRICE)

4.1 France Neuromodulation Devices Sales and Value (2011-2016)
  4.1.1 France Neuromodulation Devices Sales and Growth Rate (2011-2016)
  4.1.2 France Neuromodulation Devices Revenue and Growth Rate (2011-2016)
  4.1.4 France Neuromodulation Devices Sales Price Trend (2011-2016)
4.2 France Neuromodulation Devices Sales and Market Share by Manufacturers
4.3 France Neuromodulation Devices Sales and Market Share by Type
4.4 France Neuromodulation Devices Sales and Market Share by Application

5 UK NEUROMODULATION DEVICES (VOLUME, VALUE AND SALES PRICE)

5.1 UK Neuromodulation Devices Sales and Value (2011-2016)
  5.1.1 UK Neuromodulation Devices Sales and Growth Rate (2011-2016)
  5.1.2 UK Neuromodulation Devices Revenue and Growth Rate (2011-2016)
  5.1.5 UK Neuromodulation Devices Sales Price Trend (2011-2016)
5.2 UK Neuromodulation Devices Sales and Market Share by Manufacturers
5.3 UK Neuromodulation Devices Sales and Market Share by Type
5.4 UK Neuromodulation Devices Sales and Market Share by Application

6 RUSSIA NEUROMODULATION DEVICES (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Neuromodulation Devices Sales and Value (2011-2016)
  6.1.1 Russia Neuromodulation Devices Sales and Growth Rate (2011-2016)
  6.1.2 Russia Neuromodulation Devices Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Neuromodulation Devices Sales Price Trend (2011-2016)
6.2 Russia Neuromodulation Devices Sales and Market Share by Manufacturers
6.3 Russia Neuromodulation Devices Sales and Market Share by Type
6.4 Russia Neuromodulation Devices Sales and Market Share by Application

7 ITALY NEUROMODULATION DEVICES (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Neuromodulation Devices Sales and Value (2011-2016)
  7.1.1 Italy Neuromodulation Devices Sales and Growth Rate (2011-2016)
  7.1.2 Italy Neuromodulation Devices Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Neuromodulation Devices Sales Price Trend (2011-2016)
7.2 Italy Neuromodulation Devices Sales and Market Share by Manufacturers
7.3 Italy Neuromodulation Devices Sales and Market Share by Type
7.4 Italy Neuromodulation Devices Sales and Market Share by Application

8 SPAIN NEUROMODULATION DEVICES (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Neuromodulation Devices Sales and Value (2011-2016)
  8.1.1 Spain Neuromodulation Devices Sales and Growth Rate (2011-2016)
  8.1.2 Spain Neuromodulation Devices Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Neuromodulation Devices Sales Price Trend (2011-2016)
8.2 Spain Neuromodulation Devices Sales and Market Share by Manufacturers
8.3 Spain Neuromodulation Devices Sales and Market Share by Type
8.4 Spain Neuromodulation Devices Sales and Market Share by Application

9 BENELUX NEUROMODULATION DEVICES (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Neuromodulation Devices Sales and Value (2011-2016)
  9.1.1 Benelux Neuromodulation Devices Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Neuromodulation Devices Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Neuromodulation Devices Sales Price Trend (2011-2016)
9.2 Benelux Neuromodulation Devices Sales and Market Share by Manufacturers
9.3 Benelux Neuromodulation Devices Sales and Market Share by Type
9.4 Benelux Neuromodulation Devices Sales and Market Share by Application

10 EUROPE NEUROMODULATION DEVICES MANUFACTURERS ANALYSIS

10.1 Medtronic, Inc.
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Neuromodulation Devices Product Type, Application and Specification
    10.1.2.1 Type I
    10.1.2.2 Type II
  10.1.3 Medtronic, Inc. Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 Boston Scientific Corporation
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Neuromodulation Devices Product Type, Application and Specification
    10.2.2.1 Type I
    10.2.2.2 Type II
  10.2.3 Boston Scientific Corporation Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 St. Jude Medical, Inc
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Neuromodulation Devices Product Type, Application and Specification
    10.3.2.1 Type I
    10.3.2.2 Type II
  10.3.3 St. Jude Medical, Inc Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Synapse Biomedical, Inc.
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Neuromodulation Devices Product Type, Application and Specification
    10.4.2.1 Type I
    10.4.2.2 Type II
  10.4.3 Synapse Biomedical, Inc. Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 Nevro Corporation
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Neuromodulation Devices Product Type, Application and Specification
    10.5.2.1 Type I
    10.5.2.2 Type II
  10.5.3 Nevro Corporation Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Neurosigma, Inc.
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Neuromodulation Devices Product Type, Application and Specification
    10.6.2.1 Type I
    10.6.2.2 Type II
  10.6.3 Neurosigma, Inc. Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 Neuropace, Inc.
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Neuromodulation Devices Product Type, Application and Specification
    10.7.2.1 Type I
    10.7.2.2 Type II
  10.7.3 Neuropace, Inc. Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview
10.8 Neuronetics, Inc.
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Neuromodulation Devices Product Type, Application and Specification
    10.8.2.1 Type I
    10.8.2.2 Type II
  10.8.3 Neuronetics, Inc. Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
  10.8.4 Main Business/Business Overview
10.9 Cyberonics, Inc.
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Neuromodulation Devices Product Type, Application and Specification
    10.9.2.1 Type I
    10.9.2.2 Type II
  10.9.3 Cyberonics, Inc. Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
  10.9.4 Main Business/Business Overview
10.10 BioControl Medical
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Neuromodulation Devices Product Type, Application and Specification
    10.10.2.1 Type I
    10.10.2.2 Type II
  10.10.3 BioControl Medical Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
  10.10.4 Main Business/Business Overview

11 NEUROMODULATION DEVICES MANUFACTURING COST ANALYSIS

11.1 Neuromodulation Devices Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Neuromodulation Devices

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Neuromodulation Devices Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Neuromodulation Devices Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE NEUROMODULATION DEVICES MARKET FORECAST (2016-2021)

14.1 Germany Neuromodulation Devices Sales Forecast (2016-2021)
14.2 France Neuromodulation Devices Sales Forecast (2016-2021)
14.3 UK Neuromodulation Devices Sales Forecast (2016-2021)
14.4 Russia Neuromodulation Devices Sales Forecast (2016-2021)
14.5 Italy Neuromodulation Devices Sales Forecast (2016-2021)
14.6 Spain Neuromodulation Devices Sales Forecast (2016-2021)
14.7 Benelux Neuromodulation Devices Sales Forecast (2016-2021)
14.8 Europe Neuromodulation Devices Sales Forecast by Type (2016-2021)
14.9 Europe Neuromodulation Devices Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Neuromodulation Devices
Table Classification of Neuromodulation Devices
Figure Europe Sales Market Share of Neuromodulation Devices by Type in 2015
Figure Deep Brain Stimulation (DBS) Systems Picture
Figure Spinal Cord Stimulator (SCS) Systems Picture
Figure Diaphragm Pacing System (DPS) Picture
Figure Respiratory Electrical Stimulation (RES) Picture
Figure Vagus Nerve Stimulation (VNS) Picture
Figure Gastric Electrical Stimulation (GES) Picture
Figure Transcranial Magnetic Stimulation (TMS) Picture
Figure Transcutaneous Electrical Nerve Stimulation (TENS) Picture
Table Application of Neuromodulation Devices
Figure Europe Sales Market Share of Neuromodulation Devices by Application in 2015
Figure Chronic Pain Examples
Figure Parkinson's disease Examples
Figure Urine Incontinence Examples
Figure Epilepsy Examples
Figure Others Examples
Figure Germany Neuromodulation Devices Revenue and Growth Rate (2011-2021)
Figure France Neuromodulation Devices Revenue and Growth Rate (2011-2021)
Figure UK Neuromodulation Devices Revenue and Growth Rate (2011-2021)
Figure Russia Neuromodulation Devices Revenue and Growth Rate (2011-2021)
Figure Italy Neuromodulation Devices Revenue and Growth Rate (2011-2021)
Figure Spain Neuromodulation Devices Revenue and Growth Rate (2011-2021)
Figure Benelux Neuromodulation Devices Revenue and Growth Rate (2011-2021)
Figure Europe Neuromodulation Devices Sales and Growth Rate (2011-2021)
Figure Europe Neuromodulation Devices Revenue and Growth Rate (2011-2021)
Table Europe Neuromodulation Devices Sales of Key Manufacturers (2015 and 2016)
Table Europe Neuromodulation Devices Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Neuromodulation Devices Sales Share by Manufacturers
Figure 2016 Neuromodulation Devices Sales Share by Manufacturers
Table Europe Neuromodulation Devices Revenue by Manufacturers (2015 and 2016)
Table Europe Neuromodulation Devices Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Neuromodulation Devices Revenue Share by Manufacturers
Table 2016 Europe Neuromodulation Devices Revenue Share by Manufacturers
Table Europe Neuromodulation Devices Sales and Market Share by Type (2011-2016)
Table Europe Neuromodulation Devices Sales Share by Type (2011-2016)
Figure Sales Market Share of Neuromodulation Devices by Type (2011-2016)
Figure Europe Neuromodulation Devices Sales Growth Rate by Type (2011-2016)
Table Europe Neuromodulation Devices Revenue and Market Share by Type (2011-2016)
Table Europe Neuromodulation Devices Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Neuromodulation Devices by Type (2011-2016)
Figure Europe Neuromodulation Devices Revenue Growth Rate by Type (2011-2016)
Table Europe Neuromodulation Devices Sales and Market Share by Countries (2011-2016)
Table Europe Neuromodulation Devices Sales Share by Countries (2011-2016)
Figure Sales Market Share of Neuromodulation Devices by Countries (2011-2016)
Table Europe Neuromodulation Devices Revenue and Market Share by Countries (2011-2016)
Table Europe Neuromodulation Devices Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Neuromodulation Devices by Countries (2011-2016)
Table Europe Neuromodulation Devices Sales and Market Share by Application (2011-2016)
Table Europe Neuromodulation Devices Sales Share by Application (2011-2016)
Figure Sales Market Share of Neuromodulation Devices by Application (2011-2016)
Figure Germany Neuromodulation Devices Sales and Growth Rate (2011-2016)
Figure Germany Neuromodulation Devices Revenue and Growth Rate (2011-2016)
Figure Germany Neuromodulation Devices Sales Price Trend (2011-2016)
Table Germany Neuromodulation Devices Sales by Manufacturers (2015 and 2016)
Table Germany Neuromodulation Devices Market Share by Manufacturers (2015 and 2016)
Table Germany Neuromodulation Devices Sales by Type (2015 and 2016)
Table Germany Neuromodulation Devices Market Share by Type (2015 and 2016)
Table Germany Neuromodulation Devices Sales by Application (2015 and 2016)
Table Germany Neuromodulation Devices Market Share by Application (2015 and 2016)
Figure France Neuromodulation Devices Sales and Growth Rate (2011-2016)
Figure France Neuromodulation Devices Revenue and Growth Rate (2011-2016)
Figure France Neuromodulation Devices Sales Price Trend (2011-2016)
Table France Neuromodulation Devices Sales by Manufacturers (2015 and 2016)
Table France Neuromodulation Devices Market Share by Manufacturers (2015 and 2016)
Table France Neuromodulation Devices Sales by Type (2015 and 2016)
Table France Neuromodulation Devices Market Share by Type (2015 and 2016)
Table France Neuromodulation Devices Sales by Application (2015 and 2016)
Table France Neuromodulation Devices Market Share by Application (2015 and 2016)
Figure UK Neuromodulation Devices Sales and Growth Rate (2011-2016)
Figure UK Neuromodulation Devices Revenue and Growth Rate (2011-2016)
Figure UK Neuromodulation Devices Sales Price Trend (2011-2016)
Table UK Neuromodulation Devices Sales by Manufacturers (2015 and 2016)
Table UK Neuromodulation Devices Market Share by Manufacturers (2015 and 2016)
Table UK Neuromodulation Devices Sales by Type (2015 and 2016)
Table UK Neuromodulation Devices Market Share by Type (2015 and 2016)
Table UK Neuromodulation Devices Sales by Application (2015 and 2016)
Table UK Neuromodulation Devices Market Share by Application (2015 and 2016)
Figure Russia Neuromodulation Devices Sales and Growth Rate (2011-2016)
Figure Russia Neuromodulation Devices Revenue and Growth Rate (2011-2016)
Figure Russia Neuromodulation Devices Sales Price Trend (2011-2016)
Table Russia Neuromodulation Devices Sales by Manufacturers (2015 and 2016)
Table Russia Neuromodulation Devices Market Share by Manufacturers (2015 and 2016)
Table Russia Neuromodulation Devices Sales by Type (2015 and 2016)
Table Russia Neuromodulation Devices Market Share by Type (2015 and 2016)
Table Russia Neuromodulation Devices Sales by Application (2015 and 2016)
Table Russia Neuromodulation Devices Market Share by Application (2015 and 2016)
Figure Italy Neuromodulation Devices Sales and Growth Rate (2011-2016)
Figure Italy Neuromodulation Devices Revenue and Growth Rate (2011-2016)
Figure Italy Neuromodulation Devices Sales Price Trend (2011-2016)
Table Italy Neuromodulation Devices Sales by Manufacturers (2015 and 2016)
Table Italy Neuromodulation Devices Market Share by Manufacturers (2015 and 2016)
Table Italy Neuromodulation Devices Sales by Type (2015 and 2016)
Table Italy Neuromodulation Devices Market Share by Type (2015 and 2016)
Table Italy Neuromodulation Devices Sales by Application (2015 and 2016)
Table Italy Neuromodulation Devices Market Share by Application (2015 and 2016)
Figure Spain Neuromodulation Devices Sales and Growth Rate (2011-2016)
Figure Spain Neuromodulation Devices Revenue and Growth Rate (2011-2016)
Figure Spain Neuromodulation Devices Sales Price Trend (2011-2016)
Table Spain Neuromodulation Devices Sales by Manufacturers (2015 and 2016)
Table Spain Neuromodulation Devices Market Share by Manufacturers (2015 and 2016)
Table Spain Neuromodulation Devices Sales by Type (2015 and 2016)
Table Spain Neuromodulation Devices Market Share by Type (2015 and 2016)
Table Spain Neuromodulation Devices Sales by Application (2015 and 2016)
Table Spain Neuromodulation Devices Market Share by Application (2015 and 2016)
Figure Benelux Neuromodulation Devices Sales and Growth Rate (2011-2016)
Figure Benelux Neuromodulation Devices Revenue and Growth Rate (2011-2016)
Figure Benelux Neuromodulation Devices Sales Price Trend (2011-2016)
Table Benelux Neuromodulation Devices Sales by Manufacturers (2015 and 2016)
Table Benelux Neuromodulation Devices Market Share by Manufacturers (2015 and 2016)
Table Benelux Neuromodulation Devices Sales by Type (2015 and 2016)
Table Benelux Neuromodulation Devices Market Share by Type (2015 and 2016)
Table Benelux Neuromodulation Devices Sales by Application (2015 and 2016)
Table Benelux Neuromodulation Devices Market Share by Application (2015 and 2016)
Table Neuromodulation Devices Basic Information List
Table Medtronic, Inc. Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Medtronic, Inc. Neuromodulation Devices Sales Market Share (2011-2016)
Table Boston Scientific Corporation Basic Information List
Table Boston Scientific Corporation Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boston Scientific Corporation Neuromodulation Devices Sales Market Share (2011-2016)
Table St. Jude Medical, Inc Basic Information List
Table St. Jude Medical, Inc Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
Table St. Jude Medical, Inc Neuromodulation Devices Sales Market Share (2011-2016)
Table Synapse Biomedical, Inc. Basic Information List
Table Synapse Biomedical, Inc. Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
Table Synapse Biomedical, Inc. Neuromodulation Devices Sales Market Share (2011-2016)
Table Nevro Corporation Basic Information List
Table Nevro Corporation Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
Table Nevro Corporation Neuromodulation Devices Sales Market Share (2011-2016)
Table Neurosigma, Inc. Basic Information List
Table Neurosigma, Inc. Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
Table Neurosigma, Inc. Neuromodulation Devices Sales Market Share (2011-2016)
Table Neuropace, Inc. Basic Information List
Table Neuropace, Inc. Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
Table Neuropace, Inc. Neuromodulation Devices Sales Market Share (2011-2016)
Table Neuronetics, Inc. Basic Information List
Table Neuronetics, Inc. Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
Table Neuronetics, Inc. Neuromodulation Devices Sales Market Share (2011-2016)
Table Cyberonics, Inc. Basic Information List
Table Cyberonics, Inc. Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cyberonics, Inc. Neuromodulation Devices Sales Market Share (2011-2016)
Table BioControl Medical Basic Information List
Table BioControl Medical Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
Table BioControl Medical Neuromodulation Devices Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Neuromodulation Devices
Figure Manufacturing Process Analysis of Neuromodulation Devices
Figure Neuromodulation Devices Industrial Chain Analysis
Table Raw Materials Sources of Neuromodulation Devices Major Manufacturers in 2015
Table Major Buyers of Neuromodulation Devices
Table Distributors/Traders List
Figure Germany Neuromodulation Devices Sales and Growth Rate Forecast (2016-2021)
Figure Germany Neuromodulation Devices Revenue and Growth Rate Forecast (2016-2021)
Figure France Neuromodulation Devices Sales and Growth Rate Forecast (2016-2021)
Figure France Neuromodulation Devices Revenue and Growth Rate Forecast (2016-2021)
Figure UK Neuromodulation Devices Sales and Growth Rate Forecast (2016-2021)
Figure UK Neuromodulation Devices Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Neuromodulation Devices Sales and Growth Rate Forecast (2016-2021)
Figure Russia Neuromodulation Devices Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Neuromodulation Devices Sales and Growth Rate Forecast (2016-2021)
Figure Italy Neuromodulation Devices Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Neuromodulation Devices Sales and Growth Rate Forecast (2016-2021)
Figure Spain Neuromodulation Devices Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Neuromodulation Devices Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Neuromodulation Devices Revenue and Growth Rate Forecast (2016-2021)
Table Europe Neuromodulation Devices Sales Forecast by Type (2016-2021)
Table Europe Neuromodulation Devices Sales Forecast by Application (2016-2021)